Sidebar

Login Form

Remember Me

Forgot your username?
Forgot your password?

About
Services
Jihadist Threat
Far-Right/Far-Left
Bioterrorism
Southeast Asia
South Central Asia
Finance
Energy
Technology & Terrorism
Guide Tracker
Contact
inSITE Reports
SourceFeed

SITE Enterprise

Services

Platforms

Enterprise

SourceFeed

SearchFeed

Enterprise Services

Jihadist Threat

Far-Right/Far-Left

Bioterrorism

Southeast Asia

South Central Asia

Finance

Energy

Technology & Terrorism

Guide Tracker
About
Contact Us

Login to your account

Remember Me

Username

Password

Remember Me

Forgot your username?
Forgot your password?

Jihadist Threat
Official Statements
Chatter
Groups
Media Groups
Individuals
Multimedia
Browse All
Far-Right Far-Left
Bioterrorism
Asias
SE Asia
Central Asia
Finance
Energy
Tech & Terrorism
inSITE Reports
Articles & Analysis
RUS/UKR

Jihadist Threat
Official Statements
Chatter
Groups
Media Groups
Individuals
Multimedia
Browse All
Far-Right Far-Left
Bioterrorism
Asias
SE Asia
Central Asia
Finance
Energy
Tech & Terrorism
inSITE Reports
Articles & Analysis
RUS/UKR

AstraZeneca & Pharma Targeted with Misinformation, Violence Incitements Following News of EUA Request, Blood Clot Study

Details: Bioterrorism and Public Health; March 23, 2021

AZVaxCover

NOTE: The following materials are for information purposes only and may not be copied, reproduced, or transmitted without the explicit permission of SITE Intelligence Group and specific attribution to SITE Intelligence Group.

You are here:
Home
Bioterrorism
AstraZeneca & Pharma Targeted with Misinformation, Violence Incitements Following News of EUA Request, Blood Clot Study

SITE Intelligence Group
4938 Hampden Lane, Suite #156
Bethesda, MD 20814
Local 1.301.841.7740

Links

Terms & Conditions

Twitter

Jihadist Threat

Far-Right/Far-Left

© 2010 - 2022 siteintelgroup.com, a part of SITE Intelligence Group. All rights reserved.